• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供者安全:世界骨髓捐献者协会在确保志愿非亲缘供者安全方面的作用:临床和伦理方面的考虑。

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.

机构信息

Department of Haematology, Anthony Nolan Trust, Royal Free Hospital, London, UK.

出版信息

Bone Marrow Transplant. 2010 May;45(5):832-8. doi: 10.1038/bmt.2010.2. Epub 2010 Feb 22.

DOI:10.1038/bmt.2010.2
PMID:20173787
Abstract

Since the beginning of hematopoietic stem cell harvesting from volunteer unrelated donors, ensuring donor safety has been a necessary goal of all parties involved in the process. As donation of BM or PBSCs is not in the interest of the donor's own physical health, donor registries and transplantation centers must take into account both medical and ethical aspects involved in the donation procedure. One of the principal goals leading to the formation of the World Marrow Donor Association (WMDA) was to establish internationally acceptable standards for all aspects of unrelated donor care.

摘要

自从开始从志愿非亲缘供者采集造血干细胞以来,确保供者安全一直是参与这一过程的所有各方的必要目标。由于骨髓或外周血造血干细胞捐献不符合供者自身身体健康的利益,因此,供者登记处和移植中心必须考虑到捐献过程中涉及到的医学和伦理方面。成立世界骨髓捐献者协会(WMDA)的主要目标之一是为非亲缘供者照护的所有方面建立国际可接受的标准。

相似文献

1
Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.供者安全:世界骨髓捐献者协会在确保志愿非亲缘供者安全方面的作用:临床和伦理方面的考虑。
Bone Marrow Transplant. 2010 May;45(5):832-8. doi: 10.1038/bmt.2010.2. Epub 2010 Feb 22.
2
Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.监测用于移植的无关供体的国际使用情况:世界骨髓捐献者协会年度报告。
Bone Marrow Transplant. 2010 May;45(5):811-8. doi: 10.1038/bmt.2010.9. Epub 2010 Feb 15.
3
Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.参与全球造血干细胞供者和产品交换的注册机构的标准、法规和认证。
Bone Marrow Transplant. 2010 May;45(5):819-24. doi: 10.1038/bmt.2010.8. Epub 2010 Feb 22.
4
Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products.信息技术与世界骨髓捐献者协会在促进造血干细胞供者和产品国际交流标准方面的作用。
Bone Marrow Transplant. 2010 May;45(5):839-42. doi: 10.1038/bmt.2010.29. Epub 2010 Mar 1.
5
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.造血干细胞供者登记处:世界骨髓供者协会关于供者健康评估的建议。
Bone Marrow Transplant. 2008 Jul;42(1):9-14. doi: 10.1038/bmt.2008.76. Epub 2008 Mar 24.
6
International exchange of cord blood units: the registry aspects.脐带血单位的国际交流:注册方面。
Bone Marrow Transplant. 2010 May;45(5):825-31. doi: 10.1038/bmt.2010.11. Epub 2010 Mar 1.
7
World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.世界骨髓捐献者协会:非血缘造血干细胞捐献者登记机构国际标准
Bone Marrow Transplant. 2004 Jul;34(2):103-10. doi: 10.1038/sj.bmt.1704542.
8
A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).特别报告:世界骨髓捐献者协会(WMDA)捐献者登记处和质量保证工作组提出的国际非亲缘供者检索建议程序。
Bone Marrow Transplant. 2004 Jul;34(2):97-101. doi: 10.1038/sj.bmt.1704541.
9
The World Marrow Donor Association (WMDA): its goals and activities.世界骨髓捐献者协会(WMDA):其目标与活动
Bone Marrow Transplant. 2003 Jul;32(2):121-4. doi: 10.1038/sj.bmt.1704097.
10
Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association.造血干细胞捐献者的报酬:世界骨髓捐献者协会的原则和观点。
Blood. 2011 Jan 6;117(1):21-5. doi: 10.1182/blood-2010-07-298430. Epub 2010 Oct 4.

引用本文的文献

1
Safety of hematopoietic stem cell donation from young related donors following the lowering of the age of legal adulthood in Japan.日本法定成年年龄降低后年轻亲属造血干细胞捐献的安全性
Int J Hematol. 2025 May 20. doi: 10.1007/s12185-025-04007-y.
2
Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss.小体积骨髓抽吸并高浓度祖细胞可最大化细胞治疗剂量生产,并显著减少供体血红蛋白丢失。
BMC Med. 2023 Sep 19;21(1):360. doi: 10.1186/s12916-023-03059-3.
3
From Unit to Dose: A Machine Learning Approach for Precise Prediction of Hemoglobin and Iron Content in Individual Packed Red Blood Cell Units.
从单位到剂量:一种用于精确预测单个袋装红细胞单位中血红蛋白和铁含量的机器学习方法。
Adv Sci (Weinh). 2022 Dec;9(36):e2204077. doi: 10.1002/advs.202204077. Epub 2022 Nov 4.
4
Aging, Bone Marrow and Next-Generation Sequencing (NGS): Recent Advances and Future Perspectives.衰老、骨髓和下一代测序(NGS):最新进展和未来展望。
Int J Mol Sci. 2021 Nov 12;22(22):12225. doi: 10.3390/ijms222212225.
5
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.与无关供者相比,相关外周血造血干细胞供者在一年时的症状更严重,恢复更不完全。
Haematologica. 2019 Apr;104(4):844-854. doi: 10.3324/haematol.2018.200121. Epub 2018 Oct 31.
6
The effect of bone marrow graft composition on pediatric bone marrow transplantation outcomes.骨髓移植成分对儿童骨髓移植结果的影响。
Pediatr Transplant. 2018 Dec;22(8):e13287. doi: 10.1111/petr.13287. Epub 2018 Aug 29.
7
Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.相关单倍型相合供体比匹配的无关供体是更好的选择:反对观点。
Blood Adv. 2017 Feb 14;1(6):401-406. doi: 10.1182/bloodadvances.2016002188.
8
Hematopoietic Stem Cell Transplantation: A Bioethical Lens.造血干细胞移植:生物伦理学视角
Stem Cells Int. 2017;2017:1286246. doi: 10.1155/2017/1286246. Epub 2017 Jun 27.
9
Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations.异基因造血干细胞移植的供体选择:临床与伦理考量
Stem Cells Int. 2017;2017:5250790. doi: 10.1155/2017/5250790. Epub 2017 Jun 7.
10
GMP-conformant on-site manufacturing of a CD133 stem cell product for cardiovascular regeneration.用于心血管再生的CD133干细胞产品的符合GMP规范的现场生产。
Stem Cell Res Ther. 2017 Feb 10;8(1):33. doi: 10.1186/s13287-016-0467-0.